Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01620086 · ClinicalTrials.gov registry record · NA
Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01620086 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 26 participants.
The verdict
NCT01620086, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study compares the efficacy of low and high frequency repetitive transcranial magnetic stimulation (rTMS) as a means of treating subjects with schizophrenia. Magnetic pulses delivered over the scalp cause brain activity. This activity has been shown to help decrease the intensity and frequency of auditory hallucinations (AH) in schizophrenia. The investigators will compare whether low or high frequencies work best. The investigators will also examine what changes occur in the brain that are related to improvement.
Interventions
- DEVICE Active Repetitive Transcranial Magnetic Stimulation 1 Hz
- DEVICE Active Repetitive Transcranial Magnetic Stimulation 10 Hz
- DEVICE Active control site Repetitive Transcranial Magnetic Stimulation at 1Hz
- DEVICE Sham control site Repetitive Transcranial Magnetic Stimulation
- DEVICE Active control site Repetitive Transcranial Magnetic Stimulation at 10 Hz
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01620086
The ClinicalTrials.gov registry entry for NCT01620086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Active Repetitive Transcranial Magnetic Stimulation 1 Hz is the first listed.
NCT01620086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01620086 about?
NCT01620086 is a clinical study titled "Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia". This study compares the efficacy of low and high frequency repetitive transcranial magnetic stimulation (rTMS) as a means of treating subjects with schizophrenia. Magnetic pulses delivered over the scalp cause brain activity. This activity has been shown to help decrease the intensity and frequency ...
What is the current status of trial NCT01620086?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2012-06. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01620086?
The interventions under investigation include: Active Repetitive Transcranial Magnetic Stimulation 1 Hz (DEVICE), Active Repetitive Transcranial Magnetic Stimulation 10 Hz (DEVICE), Active control site Repetitive Transcranial Magnetic Stimulation at 1Hz (DEVICE), Sham control site Repetitive Transcranial Magnetic Stimulation (DEVICE), Active control site Repetitive Transcranial Magnetic Stimulation at 10 Hz (DEVICE).
Who is sponsoring clinical trial NCT01620086?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.